India's Covid-19 caseload rises to 1,05,95,660; recovery rate at 96.7%

The total number of people who have recuperated from the disease surged to 1,02,45,741, pushing the national Covid-19 recovery rate to 96.70 per cent

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

Press Trust of India  |  New Delhi 

A health worker shows a Covidshield vaccine vial, after the virtual launch of COVID-19 vaccination drive by Prime Minister Narendra Modi at RML Hospital in New Delhi.
A health worker shows a Covidshield vaccine vial, after the virtual launch of COVID-19 vaccination drive by Prime Minister Narendra Modi at RML Hospital in New Delhi.

With 13,823 infections reported in a day, India's COVID-19 caseload rose to 1,05,95,660, while the recoveries surged to 1,02,45,741, the Union health ministry said on Wednesday.

Thedeath toll due to the disease increased to 1,52,718in the country as 162 new fatalities were recorded, the ministry data updated at 8 am showed.

Thetotal number of people who have recuperated from the disease surged to 1,02,45,741,pushing the national COVID-19 recovery rate to 96.70 percent.

TheCOVID-19casefatality rate stands at 1.44per cent, it said.

The active caseload remained below 3 lakh. There are1,97,201 active infections in the country, which comprises1.86 per cent of the total caseload,the data stated.

India's COVID-19 tally had crossed the 20 lakh-mark on August 7,30 lakhon August 23, 40 lakh on September 5 and50 lakh onSeptember 16. It went past 60 lakh on September 28,70 lakh on October 11, 80 lakh on October 29,90 lakh on November 20 and surpassed the one crore-mark on December 19.

According to the Indian Council of Medical Research (ICMR),18,85,66,947 samples have been tested till January 19, with7,64,120 samples being tested on Tuesday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Wed, January 20 2021. 10:28 IST
RECOMMENDED FOR YOU